13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0001214659-25-007553
Total Value
$733.1M
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 3,670,206 | $89.9M | 12.26% |
| 2 | COGENT BIOSCIENCES INC | COGT | 6,964,375 | $41.7M | 5.69% |
| 3 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,890,816 | $41.6M | 5.67% |
| 4 | MINERALYS THERAPEUTICS INC | MLYS | 2,470,265 | $39.2M | 5.35% |
| 5 | OCULAR THERAPEUTIX INC | OCUL | 5,319,148 | $39.0M | 5.32% |
| 6 | ABIVAX SA AMERICAN DEPOSITARY SHARES | AAVXF | 6,056,596 | $37.9M | 5.16% |
| 7 | SAVARA INC | SVRA | 12,362,205 | $34.2M | 4.67% |
| 8 | DYNE THERAPEUTICS INC | DYN | 2,650,150 | $27.7M | 3.78% |
| 9 | DIANTHUS THERAPEUTICS INC | DNTH | 1,501,624 | $27.2M | 3.72% |
| 10 | TYRA BIOSCIENCES INC | TYRA | 2,898,103 | $27.0M | 3.68% |
| 11 | XENCOR INC | XNCR | 2,452,138 | $26.1M | 3.56% |
| 12 | DISC MEDICINE INC | IRON | 465,257 | $23.1M | 3.15% |
| 13 | TOURMALINE BIO INC | 89157D105 | 1,477,593 | $22.5M | 3.07% |
| 14 | CIDARA THERAPEUTICS INC | 171757206 | 1,005,901 | $21.7M | 2.96% |
| 15 | AMYLYX PHARMACEUTICALS INC | AMLX | 5,943,812 | $21.0M | 2.87% |
| 16 | SOLENO THERAPEUTICS INC | SLNO | 275,000 | $19.6M | 2.68% |
| 17 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,572,335 | $19.4M | 2.64% |
| 18 | STRUCTURE THERAPEUTICS INC | GPCR | 1,063,000 | $18.4M | 2.51% |
| 19 | UPSTREAM BIO INC | UPB | 2,801,763 | $17.1M | 2.34% |
| 20 | RAPT Therapeutics, Inc. | 75382E109 | 13,090,200 | $16.0M | 2.18% |
| 21 | FULCRUM THERAPEUTICS INC | FULC | 5,250,000 | $15.1M | 2.06% |
| 22 | ASTRIA THERAPEUTICS INC | 04635X102 | 2,761,861 | $14.7M | 2.01% |
| 23 | TANGO THERAPEUTICS INC | TNGX | 10,736,000 | $14.7M | 2.01% |
| 24 | COMPASS PATHWAYS LTD | CMPS | 3,858,000 | $11.0M | 1.51% |
| 25 | KURA ONCOLOGY INC | KURA | 1,423,642 | $9.4M | 1.28% |
| 26 | THIRD HARMONIC BIO INC | 88427A107 | 2,505,424 | $8.7M | 1.19% |
| 27 | SILENCE THERAPEUTICS PLC | SLNCF | 3,033,560 | $8.6M | 1.17% |
| 28 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,796,482 | $7.9M | 1.07% |
| 29 | VISTAGEN THERAPEUTICS INC | VTGN | 2,676,580 | $6.7M | 0.91% |
| 30 | AEROVATE THERAPEUTICS INC | 008064107 | 2,240,809 | $5.6M | 0.77% |
| 31 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $5.3M | 0.72% |
| 32 | MBX BIOSCIENCES INC | MBX | 650,000 | $4.8M | 0.65% |
| 33 | AVALO THERAPEUTICS INC | AVTX | 483,000 | $3.9M | 0.53% |
| 34 | KODIAK SCIENCES INC | KOD | 1,145,538 | $3.2M | 0.44% |
| 35 | NEKTAR THERAPEUTICS | NKTR | 4,000,000 | $2.7M | 0.37% |
| 36 | VENTYX BIOSCIENCES INC | 92332V107 | 316,195 | $363,624 | 0.05% |
| 37 | CABALETTA BIO INC | CABA | 86,795 | $120,211 | 0.02% |
| 38 | KEROS THERAPEUTICS INC | KROS | 0 | $0 | 0.00% |